Collplant Holdings Ltd., of Ness Ziona, Israel, a regenerative medicine company using plant-based recombinant human collagen technology for tissue repair products, is voluntarily delisting its ordinary shares and series I warrants and series K warrants from trading on the Tel Aviv Stock Exchange.